Condensed Statement of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows from Operating Activities:
Net income	$ 8,161,808	$ 3,281,083
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of warrant liabilities	(8,618,950)	(3,851,020)
Transaction costs allocated to warrant liabilities	0	465,914
Interest earned on investments held in Trust Account	(34,183)	(8,483)
Formation costs paid by Sponsor	0	5,000
Changes in operating assets and liabilities:
Prepaid expenses	44,484	(841,537)
Accrued expenses	288,167	69,701
Net cash used in operating activities	(158,674)	(879,342)
Cash Flows from Investing Activities:
Investment of cash in Trust Account		(408,454,760)
Net cash used in investing activities		(408,454,760)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid		400,285,665
Proceeds from sale of Private Placement Warrants		10,169,095
Proceeds from Promissory Note – related party		29,878
Repayment of Promissory Note – related party		(140,368)
Payment of offering costs	0	(457,588)
Net cash provided by financing activities	0	409,886,682
Net Change in Cash	(158,674)	552,580
Cash – Beginning	215,489	0
Cash – End	56,815	552,580
Non-Cash Investing and Financing Activities:
Offering costs paid by Sponsor in exchange for issuance of Founder Shares		20,000
Offering costs paid through Promissory note		110,490
Deferred underwriting fee payable	$ 14,295,917	14,295,917
Forfeiture of Founder shares		$ (14)